ELI
DEAD

Serial Number

98612645

Owner

Eli Science Inc.

Attorney

Rajesh Fotedar

Filing Date

Jun 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ELI Trademark

Serial Number: 98612645

ELI is a trademark filed by Eli Science Inc. on June 21, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Eli Science Inc. (4 trademarks)

1001 Rue Lenoir, Suite B520
Montréal, QC H4C2Z6 , CA

Entity Type: 03

Trademark Details

Filing Date

June 21, 2024

Registration Date

Not Registered

Published for Opposition

May 6, 2025

Goods & Services

downloadable software application for analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable mobile software application for analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for presentation of data from analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable mobile software application for presentation of data from analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for analysis of hormone levels, namely, progesterone, cortisol, and estradiol detected in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for presentation of data from analysis of hormone levels, namely, progesterone, cortisol, and estradiol detected in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable mobile software application for presentation of data from analysis of hormone levels, namely, progesterone, cortisol, and estradiol detected in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; wireless communication devices for wireless transmission of medical data and medical information; wireless communication devices for wireless transmission of medical data and medical information, namely, device for transmitting data collected from a cartridge with a sample of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at home; wireless communication devices for transmitting data collected from a cartridge with a sample of saliva that measures hormones present in the sample of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at home; wireless communication devices for transmitting data collected from a cartridge with a sample of saliva that measures progesterone, cortisol, and estradiol present in the sample of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home; downloadable software application for analysis of a collected sample of saliva; downloadable mobile software application for analysis of a collected sample of saliva; downloadable software application for analysis of a collected sample of bodily fluids; downloadable mobile software application for analysis of a collected sample of bodily fluid; downloadable software application for analysis of personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at home; downloadable mobile software application for analysis of personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at home; downloadable software application for analysis of hormone levels detected in a collected sample of saliva; downloadable mobile software application for analysis of hormone levels detected in a collected sample of saliva; downloadable software application for analysis of hormone levels detected in a collected sample of bodily fluid; downloadable mobile software application for analysis of hormone levels detected in a collected sample of bodily fluid; downloadable software application for presentation of data from analysis of hormone levels in a collected sample of saliva; downloadable mobile software application for presentation of data from analysis of hormone levels in a collected sample of saliva; downloadable software application for presentation of data from analysis of hormone levels in a collected sample of bodily fluid; downloadable mobile software application for presentation of data from analysis of hormone levels in a collected sample of bodily fluid; wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data from a cartridge with a sample of saliva; wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data from a cartridge with a sample of a bodily fluids; wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data from a cartridge with a sample of personally collected bodily fluids , bodily fluids collected in a nonclinical setting, and bodily fluids collected at-home; wireless communication devices for transmitting data from a cartridge with a sample of saliva and measuring hormones present in the sample of saliva; wireless communication devices for transmitting data from a cartridge with a sample of saliva and measuring hormones present in the sample of bodily fluids

saliva collection devices for medical purposes; cartridges for collection of saliva samples for use with medical devices; cartridges for personal collection of saliva, collection of saliva in a non-clinical setting, and at-home collection of saliva, all for use with medical devices; bodily fluid sample collection devices for medical purposes; cartridge for collection of bodily fluid samples for use with medical devices; cartridge for personal collection of bodily fluids, collection of bodily fluids in a non-clinical setting, and at-home collection of bodily fluids, all for use with medical devices

medical diagnostic services for detecting levels of progesterone, cortisol, or and estradiol in personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home, all performed via computer, the internet, and global computer networks; medical diagnostic services for assessing fertility based on analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing perimenopause status based on analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home, performed via computer, the internet, and global computer networks; medical diagnostic services for monitoring conditions affecting contraception based on analysis of personally collected saliva, saliva collected in a non-clinical setting, and saliva collected at-home, performed via computer, the internet, and global computer networks; medical diagnostic services for detecting hormone levels in a collected sample of saliva, performed via computer, the internet, and global computer networks; medical diagnostic services for detecting hormone levels in a collected sample of bodily fluids , performed via computer, the internet, and global computer networks; medical diagnostic services for detecting hormone levels in a collected sample of personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at-home, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing fertility based on analysis of a collected sample of saliva, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing fertility based on analysis of a collected sample of bodily fluids, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing fertility based on analysis of a personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at-home, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing perimenopause and menopause status based on analysis of a collected sample of saliva, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing perimenopause and menopause status based on analysis of a collected sample of bodily fluids, performed via computer, the internet, and global computer networks; medical diagnostic services for assessing perimenopause and menopause status based on analysis of a collected sample of personally collected bodily fluids, bodily fluids collected in a nonclinical setting, and bodily fluids collected at-home, performed via computer, the internet, and global computer networks; medical diagnostic services for monitoring conditions affecting contraception based on analysis of a collected sample of saliva, performed via computer, the internet, and global computer networks; medical diagnostic services for monitoring conditions affecting contraception based on analysis of a collected sample of bodily fluids, performed via computer, the internet, and global computer networks; medical diagnostic services for monitoring conditions affecting contraception based on analysis of a collected sample of personally collected bodily fluids, bodily fluids collected in a non-clinical setting, and bodily fluids collected at-home, performed via computer, the internet, and global computer networks

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 2, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 2, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 31, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 31, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2025 NWOS
NEW APPLICATION ENTERED
Jun 21, 2024 NWAP